Grown Rogue International (GRUSF) Other Operating Expenses (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Other Operating Expenses came in at $246156.0 in Q1 2026, up 100.0% quarter-over-quarter from -$2324.3 billion in Q4 2025.
Grown Rogue International (GRUSF) Other Operating Expenses (2009 - 2026) Analysis & Trends
Grown Rogue International's Other Operating Expenses history runs 17 years deep, the most recent figure standing at $246156.0 for Q1 2026.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $246156.0 in Q1 2026; TTM through Mar 2026 was -$1675.6 billion, a 918540925.3% decrease from a year earlier, with the FY2025 full-year figure at $3.1 million, up 59.71% from the prior year.
- Other Operating Expenses rose to $246156.0 in Q1 2026 per GRUSF's latest filing, from -$2324.3 billion in the prior quarter.
- Across five years, Other Operating Expenses topped out at $648.6 billion in Q3 2025 and bottomed at -$2324.3 billion in Q4 2025.
- The 5-year median for Other Operating Expenses is $169923.0 (2023), against an average of -$128.9 billion.
- Across the five-year window, Other Operating Expenses tumbled 101.06% in 2022 and soared 8848263764.37% in 2025, its largest moves.
- Year by year, Other Operating Expenses stood at -$5440.0 in 2022, then jumped by 1013.2% to $49678.0 in 2023, then plunged by 85.24% to $7330.5 in 2024, then tumbled by 31706542508.12% to -$2324.3 billion in 2025, then soared by 100.0% to $246156.0 in 2026.
- Per Business Quant, the three latest GRUSF Other Operating Expenses figures stand at $246156.0 (Q1 2026), -$2324.3 billion (Q4 2025), and $648.6 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.32 Mn | 85.61 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246,156.00 |
| Dec 31, 2025 | -2,324.26 Bn |
| Sep 30, 2025 | 648.63 Bn |
| Jun 30, 2025 | 793,893.00 |
| Sep 30, 2024 | 7,330.53 |
| Jun 30, 2024 | 175,092.81 |
| Mar 31, 2024 | 118,450.00 |
| Dec 31, 2023 | 49,678.00 |
| Oct 31, 2023 | -10,237.15 |
| Jul 31, 2023 | 220,292.14 |
| Apr 30, 2023 | 169,923.00 |
| Jan 31, 2023 | 223,774.00 |
| Jan 31, 2022 | -5,440.00 |
| Jul 31, 2021 | -7,573.00 |
| Apr 30, 2021 | 258,221.56 |
| Jan 31, 2021 | 514,778.00 |
| Oct 31, 2020 | 3,810.00 |
| Jul 31, 2020 | -4,024.00 |
| Apr 30, 2020 | -5,954.00 |
| Jan 31, 2020 | -701,559.00 |